Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
TRACERtracercro.com · Low evidenceTRACER is an imaging CRO specializing in Phase 0 first-in-human clinical trials using nuclear and optical molecular imaging techniques. The company helps drug developers label compounds with fluorescent dyes or radionuclides to visualize biodistribution and pharmacokinetics, enabling faster go/no-go decisions before costly Phase 1 trials.
Parse Score